Abstract:Background: Evidence-based treatment decisions in medicine are made founded on population-level evidence obtained during randomized clinical trials. In an era of personalized medicine, these decisions should be based on the predicted benefit of a treatment on a patient-level. Survival prediction models play a central role as they incorporate the time-to-event and censoring. In medical applications uncertainty is critical especially when treatments differ in their side effect profiles or costs. Additionally, models must be adapted to local populations without diminishing performance and often without the original training data available due to privacy concern. Both points are supported by Bayesian models-yet they are rarely used. The aim of this work is to evaluate Bayesian parametric survival models on public datasets including cardiology, infectious diseases, and oncology. Materials and methods: Bayesian parametric survival models based on the Exponential and Weibull distribution were implemented as a Python package. A linear combination and a neural network were used for predicting the parameters of the distributions. A superiority design was used to assess whether Bayesian models are better than commonly used models such as Cox Proportional Hazards, Random Survival Forest, and Neural Network-based Cox Proportional Hazards. In a secondary analysis, overfitting was compared between these models. An equivalence design was used to assess whether the prediction performance of Bayesian models after model updating using Bayes rule is equivalent to retraining on the full dataset. Results: In this study, we found that Bayesian parametric survival models perform as good as state-of-the art models while requiring less hyperparameters to be tuned and providing a measure of the uncertainty of the predictions. In addition, these models were less prone to overfitting. Furthermore, we show that updating these models using Bayes rule yields equivalent performance compared to models trained on combined original and new datasets. Conclusions: Bayesian parametric survival models are non-inferior to conventional survival models while requiring less hyperparameter tuning, being less prone to overfitting, and allowing model updating using Bayes rule. Further, the Bayesian models provide a measure of the uncertainty on the statistical inference, and, in particular, on the prediction.

Bayesian networks in healthcare: Distribution by medical condition

Approach and Method for Bayesian Network Modelling: A Case Study in Pregnancy Outcomes for England and Wales

Medical idioms for clinical Bayesian network development

Locally Weighted Learning: How and when Does It Work in Bayesian Networks?

Bayesian network analysis of factors influencing type 2 diabetes, coronary heart disease, and their comorbidities

CBN: Constructing a clinical Bayesian network based on data from the electronic medical record

Bayesian Networks in Radiology

Advances in Bayesian network modelling: Integration of modelling technologies

Incorporating expert knowledge when learning Bayesian network structure: A medical case study

Learning Bayesian networks probabilities from longitudinal data

Development of Asian Non-Small Cell Lung Cancer Survival Prediction Model Using an Innovative Method of Bayesian Network.

Bayesian Network Models of Causal Interventions in Healthcare Decision Making: Literature Review and Software Evaluation

Learning Bayesian networks from demographic and health survey data

A survey of Bayesian Network structure learning

Bayesian Approach to Predicting Acute Appendicitis Using Ultrasonographic and Clinical Variables in Children

Assessing an Alternative for `Negative Variance Components': A Gentle Introduction to Bayesian Covariance Structure Modelling for Negative Associations Among Patients with Personalized Treatments

Information-Theoretic Scoring Rules to Learn Additive Bayesian Network Applied to Epidemiology

Web-tool to Support Medical Experts in Probabilistic Modelling Using Large Bayesian Networks With an Example of Hinosinusitis

Application of Bayesian Networks on Large-Scale Biological Data

Mining Causal Relationships among Clinical Variables for Cancer Diagnosis Based on Bayesian Analysis

Bayesian parametric models for survival prediction in medical applications